- Home
- AXSM vs KMX Comparison
AXSM vs KMX Comparison
Compare AXSM & KMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | KMX |
|---|---|---|
| Founded | 2012 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.1B |
| IPO Year | 2015 | 1997 |
Fundamental Metrics
Financial Performance| Metric | AXSM | KMX |
|---|---|---|
| Price | $148.69 | $41.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 20 | 17 |
| Target Price | ★ $176.00 | $44.75 |
| AVG Volume (30 Days) | 495.6K | ★ 3.7M |
| Earning Date | 11-03-2025 | 12-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.08 |
| EPS | N/A | ★ 3.40 |
| Revenue | $561,263,000.00 | ★ $28,279,819,000.00 |
| Revenue This Year | $66.20 | N/A |
| Revenue Next Year | $57.56 | $0.69 |
| P/E Ratio | ★ N/A | $11.95 |
| Revenue Growth | ★ 65.83 | 2.17 |
| 52 Week Low | $75.56 | $30.26 |
| 52 Week High | $152.94 | $91.25 |
Technical Indicators
Market Signals| Indicator | AXSM | KMX |
|---|---|---|
| Relative Strength Index (RSI) | 56.98 | 58.78 |
| Support Level | $145.07 | $40.00 |
| Resistance Level | $149.13 | $42.06 |
| Average True Range (ATR) | 4.15 | 1.21 |
| MACD | -0.77 | 0.52 |
| Stochastic Oscillator | 61.43 | 74.79 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About KMX CarMax Inc
CarMax sells, finances, and services used and new cars through a chain of over 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales were 83% of fiscal 2025 revenue and wholesale about 17%, with the remaining portion composed of extended service plans and repair. In fiscal 2025, the company retailed and wholesaled 789,050 and 544,312 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in calendar 2024. It seeks over 5% share. CarMax is based in Richmond, Virginia.